DTC Ads Should Cite Range Of Treatment Options, Blue Cross Assoc. Tells FDA
Executive Summary
Direct-to-consumer advertising should include disclosures to note when a particular drug is one of a range of available treatment choices, the Blue Cross and Blue Shield Association said in comments to FDA